Cigna Investments Inc. New boosted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 30.1% in the 1st quarter, HoldingsChannel reports. The firm owned 33,688 shares of the healthcare conglomerate’s stock after buying an additional 7,797 shares during the period. UnitedHealth Group accounts for about 1.1% of Cigna Investments Inc. New’s investment portfolio, making the stock its 11th largest holding. Cigna Investments Inc. New’s holdings in UnitedHealth Group were worth $8,400,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in UNH. Norges Bank bought a new position in UnitedHealth Group during the 4th quarter valued at about $2,804,376,000. Capital Research Global Investors lifted its holdings in UnitedHealth Group by 32.1% during the 4th quarter. Capital Research Global Investors now owns 29,851,016 shares of the healthcare conglomerate’s stock valued at $8,775,602,000 after purchasing an additional 7,261,158 shares during the last quarter. Capital World Investors lifted its holdings in UnitedHealth Group by 7.2% during the 4th quarter. Capital World Investors now owns 47,932,997 shares of the healthcare conglomerate’s stock valued at $14,091,342,000 after purchasing an additional 3,219,554 shares during the last quarter. NorthRock Partners LLC lifted its holdings in UnitedHealth Group by 33,159.6% during the 4th quarter. NorthRock Partners LLC now owns 1,347,680 shares of the healthcare conglomerate’s stock valued at $3,498,000 after purchasing an additional 1,343,628 shares during the last quarter. Finally, Capital International Investors lifted its holdings in UnitedHealth Group by 4.4% during the 4th quarter. Capital International Investors now owns 25,843,701 shares of the healthcare conglomerate’s stock valued at $7,597,531,000 after purchasing an additional 1,082,141 shares during the last quarter. 87.10% of the stock is owned by hedge funds and other institutional investors.
Several brokerages recently issued reports on UNH. Barclays reissued a “buy” rating and set a $322.00 price target on shares of UnitedHealth Group in a report on Sunday, March 29th. Credit Suisse Group cut their price target on shares of UnitedHealth Group from $330.00 to $325.00 and set an “outperform” rating for the company in a report on Thursday, April 16th. Raymond James dropped their target price on shares of UnitedHealth Group from $340.00 to $325.00 in a research note on Thursday, April 16th. SunTrust Banks boosted their target price on shares of UnitedHealth Group from $340.00 to $360.00 and gave the stock a “buy” rating in a research note on Thursday. Finally, Deutsche Bank dropped their target price on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a research note on Thursday, April 16th. Four investment analysts have rated the stock with a hold rating and twenty have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $319.68.
In other news, Director Stephen J. Hemsley sold 45,637 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $289.11, for a total value of $13,194,113.07. Following the completion of the transaction, the director now owns 1,013,122 shares in the company, valued at $292,903,701.42. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $212.00, for a total transaction of $1,060,000.00. Following the completion of the transaction, the director now owns 158,598 shares of the company’s stock, valued at approximately $33,622,776. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 65,637 shares of company stock valued at $17,723,013. Corporate insiders own 0.80% of the company’s stock.
NYSE UNH traded up $3.03 during trading on Friday, reaching $289.94. 2,907,540 shares of the stock traded hands, compared to its average volume of 4,276,896. The firm has a market cap of $272.10 billion, a price-to-earnings ratio of 20.29, a price-to-earnings-growth ratio of 1.41 and a beta of 0.72. The stock’s 50-day moving average price is $277.58 and its 200 day moving average price is $277.14. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 0.60. UnitedHealth Group Inc has a fifty-two week low of $187.72 and a fifty-two week high of $306.71.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.63 by $0.09. The firm had revenue of $64.40 billion during the quarter, compared to analysts’ expectations of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company earned $3.73 earnings per share. Analysts anticipate that UnitedHealth Group Inc will post 16.24 EPS for the current fiscal year.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What is a price target?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.